Skip to Main Content

Paper Details

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients.
Cancer Med
5
2020
Author NameAffiliation
Claudia Hube-MaggInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Christina M??ller-KoopInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Hartwig HulandMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Thorsten SchlommCharite-University Medical Center Berlin
  • 1 - 7

Datasets